Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives
作者： Juliette Palle , Adrien Rochand , Simon Pernot , Claire Gallois , Julien Taïeb
DOI: 10.1007/S40265-020-01272-5
关键词: Medicine 、 Cancer 、 Pharmacotherapy 、 Immunotherapy 、 Disease 、 MEDLINE 、 Population 、 Oncology 、 Retrospective cohort study 、 Internal medicine 、 Trastuzumab
摘要: … Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3).: Journal of …
springer.com
sci-hub.se 
binasss.sa.cr 参考文章(101)
Ituo Miyazaki, Shigekazu Ohoyama, Itasu Ninomiya, Akio Yamaguchi, Motohiro Tanaka, Yutaka Yonemura, Takuma Sasaki, Yoshio Endou, Sachio Fushida, Hironobu Kimura, Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Research. ,vol. 51, pp. 1034- 1038 ,(1991)
Allan Lipton, Kim Leitzel, Suhail M. Ali, Walter Carney, Greg Platek, Klaudia Steplewski, Ron Westlund, Robert Gagnon, Anne-Marie Martin, Julie Maltzman, Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy Cancer. ,vol. 117, pp. 5013- 5020 ,(2011) , 10.1002/CNCR.26101
D.P. Hollywood, H.C. Hurst, A novel transcription factor, OB2‐1, is required for overexpression of the proto‐oncogene c‐erbB‐2 in mammary tumour lines. The EMBO Journal. ,vol. 12, pp. 2369- 2375 ,(1993) , 10.1002/J.1460-2075.1993.TB05891.X
Stephen Lee, Willem Bastiaan de Boer, Soraya Fermoyle, Michael Platten, Marian Priyanthi Kumarasinghe, Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections. Histopathology. ,vol. 59, pp. 832- 840 ,(2011) , 10.1111/J.1365-2559.2011.04017.X
Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno, Yoichiro Moriya, Kazushige Mori, Yutaka Tanaka, Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Cancer Chemotherapy and Pharmacology. ,vol. 59, pp. 795- 805 ,(2007) , 10.1007/S00280-006-0337-Z
T Matsubara, H Okada, K Yamamoto, H Kinugasa, K Nouso, T Tanaka, K Miyahara, Y Morimoto, C Dohi, Droplet digital PCR measurement of HER2 in patients with gastric cancer. British Journal of Cancer. ,vol. 112, pp. 1652- 1655 ,(2015) , 10.1038/BJC.2015.129
Wenle Xia, Catherine M Gerard, Leihua Liu, Nathalie M Baudson, Thierry L Ory, Neil L Spector, Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells Oncogene. ,vol. 24, pp. 6213- 6221 ,(2005) , 10.1038/SJ.ONC.1208774
Zhao Peng, Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World Journal of Gastroenterology. ,vol. 20, pp. 5403- 5410 ,(2014) , 10.3748/WJG.V20.I18.5403
J. T. Garrett, M. G. Olivares, C. Rinehart, N. D. Granja-Ingram, V. Sanchez, A. Chakrabarty, B. Dave, R. S. Cook, W. Pao, E. McKinely, H. C. Manning, J. Chang, C. L. Arteaga, Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 5021- 5026 ,(2011) , 10.1073/PNAS.1016140108
Taroh Satoh, Rui-Hua Xu, Hyun Cheol Chung, Guo-Ping Sun, Toshihiko Doi, Jian-Ming Xu, Akihito Tsuji, Yasushi Omuro, Jin Li, Jin-Wan Wang, Hiroto Miwa, Shu-Kui Qin, Ik-Joo Chung, Kun-Huei Yeh, Ji-Feng Feng, Akihira Mukaiyama, Mikiro Kobayashi, Atsushi Ohtsu, Yung-Jue Bang, Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study Journal of Clinical Oncology. ,vol. 32, pp. 2039- 2049 ,(2014) , 10.1200/JCO.2013.53.6136